Clinical diagnosis automation offers precise operations in the field of medical diagnosis. There are various advantages associated with clinical diagnosis automation such as affordable treatment, safer solutions, fast service with high accuracy, longer-lasting equipment, less risk of lawsuits and many others. Advancements in newborn screening & breast cancer advances and technological developments in ebola diagnostics due to the growing emergence of an ebola outbreak have been supplementing the overall growth of the market. However, lack of adoption of clinical diagnostic automation among small and medium-sized laboratories and higher initial investments, as well as expensive sensors, might stagnate the demand for clinical diagnostic automation.
This growth is primarily driven by Upsurging Demand for Accurate Clinical Diagnostics and Growing Geriatric Population across the Globe.
Globally, a noticeable market trend is evident Upsurging Advancements in Newborn Screening & Breast Cancer Advances
. The Health Care Technology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Abaxis, Inc. (United States), Abbott Diagnostics, Inc. (United States), Beckman Coulter, Inc. (United States), Becton, Dickinson, and Company (United States), bioMrieux SA (France), Bio-Rad Laboratories, Inc. (United States), Diagnostica Stago S.A.S. (France), Eppendorf AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), HORIBA ABX S.A.S. (France), Hudson Robotics, Inc. (United States) and Ortho Clinical Diagnostics, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On May 6, 2019, Abbott has launched a new, smarter heart monitor for better arrhythmia detection positive news for people at risk for irregular heartbeats. Now with CE Mark in Europe and U.S. Food and Drug Administration (FDA) clearance, the next-generation Confirm Rx insertable cardiac monitor (ICM), a paperclip-sized implantable device, combines smartphone connectivity and continuous, remote monitoring to track unpredictable heart rhythm problems for a fast and accurate diagnosis.
- Upsurging Demand for Accurate Clinical Diagnostics
- Growing Geriatric Population across the Globe
- Upsurging Advancements in Newborn Screening & Breast Cancer Advances
- Upsurging Technological Developments in Ebola Diagnostics due to the growing emergence of an Ebola outbreak
- Lack of Adoption of Clinical Diagnostic Automation among Small and Medium-Sized Laboratories
- Higher Initial Investments, as well as Expensive Sensors, might Stagnate the Demand
OpportunitiesEmerging Markets Provide an Array of Opportunities to Clinical Diagnostics System Providers and Wide Scope and Increasing Adoption in Microbiology
ChallengesComplexities in Technological Installment and Existing System Integrations and Skilled Workforce required in Developing Highly Automated Systems
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the ReportAMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Clinical Diagnostics Automation Study Sheds Light on The Clinical Diagnostics Automation Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Clinical Diagnostics Automation industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Clinical Diagnostics Automation industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.